An Update on the Use of Exhaled Breath Analysis for the Early Detection of Lung Cancer
- PMID: 34429674
- PMCID: PMC8378913
- DOI: 10.2147/LCTT.S320493
An Update on the Use of Exhaled Breath Analysis for the Early Detection of Lung Cancer
Abstract
Lung cancer has historically been the main responsible for cancer associated deaths. Owing to this is our current inability to screen for and diagnose early pathological findings, preventing us from a timely intervention when cure is still achievable. Over the last decade, together with the extraordinary progress in therapeutical alternatives in the field, there has been an ongoing search for a biomarker that would allow for this. Numerous technologies have been developed but their clinical application is yet to come. In this review, we provide an update on volatile organic compounds, a non-invasive method that can hold the key for detecting early metabolic pathway changes in carcinogenesis. For its compilation, web-based search engines of scientific literature such as PubMed were explored and reviewed, using articles, research, and papers deemed meaningful by authors discretion. After a brief description, we depict how this technique can complement current methods and present the value of electronic noses in the identification of the "breathprint". Lastly, we bring some of the latest updates in the field together with the current limitations and final remarks.
Keywords: E-nose; GC-MS; VOC; biomarkers; electronic nose; lung cancer; volatile organic compounds.
© 2021 Peled et al.
Conflict of interest statement
Nir Peled is Advisor & Honorarium from Research with AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, FoundationMedicine, Guardant360, Merck, MSD, Novartis, NovellusDx, Pfizer, Roche, Takeda, and holds the following international patents (IP): Volatile Organic Compounds For Detecting Cell Dysplasia and Genetic Alterations Associated with Lung Cancer; WO2012023138 Breath Analysis of Pulmonary Nodules. US20130150261 A1. Apparatus for treating a target site of a body; WO/2015/059646. The rest of the authors hold no conflict of interest.
Figures
References
-
- Cancer. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer. Accessed January16, 2021.
-
- CDC. An update on cancer deaths in the United States. Available from: https://www.cdc.gov/cancer/dcpc/research/update-on-cancer-deaths/index.htm. Accessed January16, 2021.
-
- About lung cancer. Available from: https://www.cancer.org/cancer/lung-cancer/about/key-statistics.html. Accessed January17, 2021.
-
- Wood DE, Kazerooni EA, Aberle D, et al. NCCN guidelines version 1.2021 lung cancer screening version 1; 2021. Available from: https://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdf. Accessed January17, 2021.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
